We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Eli Lilly said Thursday that Christi Shaw will lead the company's bio-medicines business beginning April 3, succeeding David A. Ricks, who became the drugmaker's president and CEO on January 1.